Top

BY Lany Kimmons

In recognition of their contributions to basic, translational, and clinical research, six faculty members from MD Anderson Cancer Center have been named Fellows of the American Association for the Advancement of Science (AAAS). Election as a Fellow, a tradition that began in 1874, is an honor bestowed upon AAAS members by their peers. MD Anderson's faculty now includes 46 AAAS Fellows.

MD Anderson's newly elected AAAS Fellows...

Clockwise from top left: John Heymach, M.D., Ph.D., Kelly Hunt, M.D., Dimitrios Kontoyiannis, M.D., Ph.D., Frederick Lang, M.D., Zhimin (James) Lu, M.D., Ph.D., and Shao-Cong Sun, Ph.D., have been named Fellows of the American Association for the Advancement of Science.

BY Clayton Boldt, Ph.D.

Elevated levels of chronic stress hormones, such as those produced by psychological distress, may promote resistance to drugs commonly used...

BY Scott Merville

The largest analysis of metastatic melanoma patients who received a targeted therapy combination shows the treatment provides long-term survival...

BY Laura Sussman

A new-generation clinical trial for glioblastoma multiforme (GBM) — the deadliest form of brain cancer – will begin enrolling patients by mid-year 2016. The trial is designed to identify effective treatments faster for this aggressive form of brain cancer which kills half of all patients diagnosed within one year. Five years after diagnosis, the survival rate is less than 2 percent.

The international trial is adaptive, meaning...

BY Ron Gilmore

A multi-center, international, randomized, Phase III study of older untreated patients with chronic lymphocytic leukemia (CLL) demonstrated...

BY Ron Gilmore

An MD Anderson study may explain why chemotherapy drugs such as gemcitabine are ineffective against pancreatic cancer in some patients. The...

BY Scott Merville

A team led by researchers at MD Anderson Cancer Center reports a crucial tumor-thwarting gene protects an immune attack against lung cancer...

BY Ron Gillmore

Cetuximab, marketed as Erbitux®å, is one of the key therapies for metastatic colorectal cancer. Yet the cancer still returns in some patients...

BY Ron Gilmore

Leveraging recent advances in the biology of extracellular vesicles and their role in intercellular communication, Codiak BioSciences, Inc...

BY Ron Gilmore

It’s no surprise that people enjoy warm places like Hawaii, but may suffer in hostile locales such as Antarctica. A tumor suppressor gene...